Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2026-01-02 @ 3:34 AM
Study NCT ID:
NCT01439750
Status:
UNKNOWN
Last Update Posted:
2017-08-07
First Post:
2011-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)
Sponsor:
Milton S. Hershey Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-08
Completion Date Type:
ESTIMATED
First Submit Date:
2011-08-16
First Submit QC Date:
None
Study First Post Date:
2011-09-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-04
Last Update Post Date:
2017-08-07
Last Update Post Date Type:
ACTUAL